Search for: "Teva Pharmaceuticals"
Results 241 - 260
of 1,422
Sorted by Relevance
|
Sort by Date
29 Jun 2018, 11:13 am
Already on October 16, 2017, Novartis discovered that Teva was commercializing generic versions of the said pharmaceutical in France. [read post]
16 May 2019, 8:15 am
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
6 Aug 2021, 11:15 am
Court of Appeals for the Federal Circuit (CAFC) on Thursday underscored its October 2020 ruling that generic company, Teva Pharmaceuticals, was liable for induced infringement of GlaxoSmithKline’s (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol. [read post]
9 Dec 2018, 12:10 pm
Teva Pharmaceutical USA (transcript of oral arguments here). [read post]
16 Mar 2009, 8:52 pm
(a Teva Pharmaceuticals subsidiary) entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family covering Xopenex ®, an inhaled asthma treatment. [read post]
4 Jul 2008, 3:27 pm
AstraZeneca has been granted summary judgment for no inequitable conduct in Seroquel patent litigation and strategically avoided running into expensive and time-consuming expert discovery trial that was scheduled to begin on August 11 against the generic manufacturers Teva Pharmaceutical Industries and Sandoz. [read post]
8 Jun 2014, 9:09 pm
• Defendant: Teva Pharmaceuticals USA, Inc. [read post]
20 Mar 2008, 5:27 pm
The Court of Appeals for the Federal Circuit upheld a lower court ruling that Teva Pharmaceutical Industries Ltd. infringed two patents held by Pfizer Inc. for Celebrex, a non-steroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis. [read post]
3 Nov 2023, 7:15 am
The parties agreed that due to time constraints, Teva’s DNI could be heard at a later date. [read post]
23 May 2011, 9:52 pm
Teva Pharmaceuticals USADocket: 10-1070Issue(s): When a case becomes moot as the result of a third party’s independent action after the court of appeals issues a judgment but while a petition for rehearing is still pending, should the court of appeals vacate the judgment upon the request of the aggrieved party? [read post]
29 Jul 2013, 2:24 am
Those that work in the pharmaceutical industry know that generics covet the "first mover" advantage. [read post]
3 Jun 2009, 11:18 am
Reglan (metoclopramide) is prescribed for short-term treatment of gastrointestinal disorders.The Petition was opposed by several drug maker of metoclopramide including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva. [read post]
20 Feb 2015, 11:19 am
(Teva) case last week. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
1 Apr 2014, 7:03 am
Yesterday the Supreme Court granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
16 Oct 2017, 12:36 pm
Teva Pharmaceuticals USA Inc. [read post]
7 Sep 2011, 9:59 pm
By James DeGiulio -- Teva's Patents Covering Copaxone Upheld in Infringement Suit Mylan failed in its efforts to dismiss Teva's patent suit over the multiple-sclerosis drug Copaxone when the patents directed to the active pharmaceutical ingredient (API) in the drug, glatiramer acetate, were upheld as valid. [read post]
24 Nov 2020, 8:41 am
In 2017, Teva Pharmaceuticals acquired the rights to manufacture and sell the Paragard IUD. [read post]
12 Jan 2017, 12:42 pm
;Teva Pharmaceuticals USA, Inc.; and Barr Laboratories,Inc. [read post]
20 Jul 2017, 12:47 pm
On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
